1. Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
   Mengxin Wang et al, 2024, Journal of Pharmaceutical Analysis CrossRef
2. The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
   Wentao Jia et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef